FIBRINOLYSIS Flashcards
is defined as the dissolution of clot by plasmin.
Fibrinolysis
is derived from plasminogen, which is produced by the liver.
Plasmin
Dissolution of clot to restore and reestabish blood flow
FIBRINOLYSIS
Clot=
Thrombosis = ↑ Blood pressure = Aneurysm
-Dissolution of clots
FIBRINOLYSIS
-systematic, accelerating hydrolysis of fibrin by bound plasmin
FIBRINOLYSIS
-Proteins involved:
Plasminogen
Tissue plasminogen activator
Urokinase
Plasminogen activator inhibitor-1
a2-Antiplasmin Thrombin-activatable
fibrinolysis inhibitor
Plasma serine protease, plasmin digests fibrin/fibrinogen
Plasminogen
Serine protease secreted by activated endothelium, activates plasminogen
Tissue plasminogen activator
Serine protease secreted by kidney, activates plasminogen
Urokinase
Secreted by endothelium, inhibits tissue plasminogen activator
Plasminogen activator inhibitor-1
Inhibits plasmin
a2-Antiplasmin
Suppresses fibrinolysis by removing fibrin C-terminal lysine binding sites
Thrombin-activatable fibrinolysis inhibitor
: Serine protease; substrate for activation; activates plasmin (digests fibrin to fibrinogen)
Plasminogen
: digests fibrin/fibrinogen
Plasmin
: injured blood vessel that releases procoagulant substances like collagen and tissue factor
Activated endothelium
Endothelium → Activation of plasminogen →
TPA → Plasmin
: regulator of TPA/Urokinase plasminogen activator
Plasminogen activator inhibitor-1
: specifically inhibits free plasmin
a2-Antiplasmin
: activated by thrombin
TAFI
: form the kidneys and can also be produced by monocyte and macrophage
UPA
• Serine protease activated to plasmin
PLASMINOGEN
• Produced by the liver
PLASMINOGEN
• Structure: five glycosylated loops (kringles)
PLASMINOGEN
is made up of lysine amino acid
Plasminogen
: located at the C-terminal end of every loop
Lysine
allows binding to TPA or UPA in plasminogen to activate it
Lysine
binding site of the activators of plasminogen
Lysine
attaches lysine to activate plasminogen (FIBRINOLYTIC SYSTEM)
TPA/UPA
Other activators: (COAGULATION SYSTEM)
FXIIa, Kallikrein, and Thrombin + Protein C, Protein S, Protein Z, thrombomodulin
(EXOGENOUS)
urokinase and streptokinase
not produced by the body but can imitate the action of urokinase from the kidney
EXOGENOUS
synthetically produced outside the body
EXOGENOUS
can come from bacteria, medications, and food
EXOGENOUS
Functions of Plasmin
Promotes clot dissolution
Activates complement system
Fragments FXIIa
activated form of plasminogen, which digests the clot
Plasmin
: excess plasmin is released and destroyed by antiplasmin
→ Normal
: excessive free plasmin is released, antiplasmin is depleted, plasmin destroys other components
→ Abnormal
(substrates for plasmin: [?])
I, V, VIII, XIII
Plasmin cannot recognize the difference between
fibrinogen and fibrin
Fibrinogen will be depleted and exhausted from the liver until I, V, VIII depletes = [?] due to excess plasmin not destroyed by antiplasmin
prolonged bleeding
(participates in the activation of C1a, C1b, and other complement factors)
Activates complement system
(along with K, activates plasminogen to plasmin; plasmin feeds back to XII to fragment it)
Fragments FXIIa
Types of Plasmin
- Bound plasmin
- Free plasmin
: digest clots (needed by the body)
- Bound plasmin
: digest fibrinogen, FV, VIII and fibronectin
- Free plasmin
imp in plt adhesion; can destroy a lot when free in the circulation & without antiplasmin
- Free plasmin
- activates fibrinogen to become fibrin
Thrombin
- Fibrin (composition: [?] – soluble)
fibronopeptide A and fibronopeptide B
- independent; weaker; subjected to proteolysis =
soluble (no clot)
- Cross-linked fibrin is insoluble and acted upon by plasmin forming
FDPs (fibrin degradation products)
-: connects and cross-links domains/fibrinopeptides A and B
FXIII
FDPs
- Fibrin degradation products
(has both alpha and beta knobs)with 2 D domains
E central domain
connects with other D to create fibrin link
E
connects D dimer
Alpha knob
connects D domain
Beta knob
- is activated to plasmin
Plasminogen
- Plasmin works on fibrin and split them into
FDPs
- TPA and UPA is inhibited by
Plasminogen Activator Inhibitor (PAI-1) and Lipoprotein A (Lp-a)
– these two are controlled by TPA and UPA
Plasminogen Activator Inhibitor (PAI-1) and Lipoprotein A (Lp-a)
- Free plasmin (plasmin that did not participate in the clot) is inhibited by
a-2 antiplasmin
-: activates fibrinogen to fibrin, XIII to XIIIa and TAFI to TAFIa
Thrombin
(needed to control plasmin)
TAFIa
TAFI
- Thrombin-Activatable Fibrinolysis Inhibitor (TAFI)
Plasminogen is activated to Free plasmin and Bound plasmin (attached to a clot) by [?]
TPA
attaches to bound plasmin degrading fibrin to firbin degradation products (FDPs: X, Y, D, E, D-dimer)
TPA
: targets bound plasmin
3) Thrombin-activatable fibrinolysis inhibitor (TAFI)
: targets free plasmin; works on the dangerous free plasmin
2) a-2 antiplasmin
: targets activator of plasminogen
1) Plasminogen activator inhibitor-1 (PAI-1)
deactivates fibrinolysis at once/primary inhibitor/regulator of fibrinolysis
1) Plasminogen activator inhibitor-1 (PAI-1)
Fibrin (& Fibrinogen) Degradation Products (FDP):
X, Y, D (DD DIMER), E
• Four principal products by plasmin:
Fragment X,Y,D (D-D dimer) and E
: early degradation products
• X and Y
: late degradation products
• D and E
: indication of in-vivo fibrinolysis
• D-D dimer
tested for px w/ DIC where coagulation occurs inside the body by administering anticoagulants to inhibit some factors and stop coagulation
• D-D dimer
production indicates that coagulation has stopped and clot has dissolved
• D-D dimer
indicates successful fibriolysis
• D-D dimer
Fibronopeptide A
Fibronopeptide B
Fibronopeptide A is degraded by plasmin by working first on the alpha chain =
Fragment X
E and D is degraded by plasmin by working first on the D domain =
Fragment Y
composed of 1 E dmain and 1 D domain
Fragment Y
Does not contain alpha chain and 1 D-dimer
Fragment Y
E and D connects = (indication of in vivo fibrinolysis)
D-d dimer
Effects of FDP:
inhibits coagulation
: with anticoagulant effect (V and VIII)
Fragment Xand Y
: inhibit fibrin polymerization
Fragment Y and D
do not allow fibrin to connect w/ each other/no cross-linking
Fragment Y and D
: inhibits thrombin (the body cannot coagulate in the presence of FDP – control of coagulation and anticoagulant)
Fragment E